We are live on ! Find out more
VINCW

Vincerx Pharma, Inc. Warrant
VINCW

Delisted

VINCW was delisted on the 5th of May, 2021.

18 hedge funds and large institutions have $13.5M invested in Vincerx Pharma, Inc. Warrant in 2020 Q4 according to their latest regulatory filings, with 18 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
18
Holders Change
+18
Holders Change %
% of All Funds
0.32%
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
18
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
EC
1
EcoR1 Capital
California
$3.14M +$499K +150,000 New
BFM
2
Boothbay Fund Management
New York
$3.12M +$496K +149,118 New
RI
3
RTW Investments
New York
$1.65M +$1.66M +500,000 New
TCM
4
Tang Capital Management
California
$1.09M +$1.1M +330,205 New
PA
5
Perceptive Advisors
New York
$990K +$998K +300,000 New
ACM
6
Altium Capital Management
New York
$710K +$716K +215,250 New
SCM
7
Sio Capital Management
New York
$693K +$698K +210,000 New
MIM
8
Monashee Investment Management
Massachusetts
$660K +$665K +200,000 New
AAA
9
Affinity Asset Advisors
New York
$627K +$632K +190,000 New
HIM
10
HGC Investment Management
Ontario, Canada
$300K +$302K +90,700 New
RCM
11
Rivernorth Capital Management
Florida
$226K +$228K +68,513 New
HF
12
HRT Financial
New York
$127K +$128K +38,605 New
WAM
13
Wolverine Asset Management
Illinois
$98K +$99.4K +29,892 New
Walleye Trading
14
Walleye Trading
New York
$72K +$72.4K +21,758 New
Morgan Stanley
15
Morgan Stanley
New York
$12K +$11.6K +3,500 New
Wells Fargo
16
Wells Fargo
California
$10K +$9.98K +3,000 New
UBS Group
17
UBS Group
Switzerland
$3K +$3.1K +932 New
Walleye Capital
18
Walleye Capital
New York
$108 +$109K +32,635 New

VINCW Hedge Fund Activity: Q4 2020 in Review

18 of the 5,651 institutional investors tracked by Wall St. Rank reported a position in Vincerx Pharma, Inc. Warrant (VINCW) for Q4 2020, worth a combined $13.5M.

Buyers outnumbered sellers: 18 funds opened new VINCW positions and 0 closed out — a net gain of 18 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was RTW Investments, opening a new position worth an estimated $1.66M.

  • 18 institutional investors held Vincerx Pharma, Inc. Warrant (VINCW) as of Q4 2020, up from 0 in Q3 2020.
  • Funds reported $13.5M of Vincerx Pharma, Inc. Warrant stock for Q4 2020.
  • 18 funds opened new Vincerx Pharma, Inc. Warrant positions in Q4 2020 and 0 closed out, a net change of +18 holders.
  • The largest Vincerx Pharma, Inc. Warrant buyer in Q4 2020 was RTW Investments, an estimated $1.66M added.

Based on aggregated 13F filings for Q4 2020.